0.05Open0.10Pre Close13 Volume405 Open Interest82.00Strike Price47.00Turnover79.59%IV2.88%PremiumDec 27, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.03Extrinsic Value100Contract SizeAmericanOptions Type0.0548Delta0.0853Gamma2657.83Leverage Ratio-0.4527Theta0.0000Rho145.54Eff Leverage0.0018Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet